The perils of combination antithrombotic therapy and potential resolutions.
Marc
M
Fisher
Joseph
J
Loscalzo
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced* / Q000378:metabolism / Q000517:prevention & control; D006801:Humans; D012307:Risk Factors; D014652:Vascular Diseases / Q000188:drug therapy / Q000378:metabolism
D000925:Anticoagulants; D005343:Fibrinolytic Agents